AVVEDIMENTO, MARISA
 Distribuzione geografica
Continente #
AS - Asia 1.842
NA - Nord America 1.256
EU - Europa 1.237
SA - Sud America 213
AF - Africa 55
OC - Oceania 4
Totale 4.607
Nazione #
US - Stati Uniti d'America 1.206
SG - Singapore 723
RU - Federazione Russa 564
VN - Vietnam 410
CN - Cina 369
IT - Italia 300
BR - Brasile 162
HK - Hong Kong 130
DE - Germania 103
FR - Francia 65
NL - Olanda 58
GB - Regno Unito 45
BD - Bangladesh 41
KR - Corea 34
IN - India 28
CA - Canada 26
FI - Finlandia 26
JP - Giappone 25
AR - Argentina 18
CI - Costa d'Avorio 18
MX - Messico 13
EC - Ecuador 12
PL - Polonia 12
PH - Filippine 11
ZA - Sudafrica 11
ES - Italia 10
ID - Indonesia 9
IQ - Iraq 9
SE - Svezia 9
TH - Thailandia 9
AT - Austria 7
MA - Marocco 7
TW - Taiwan 7
CH - Svizzera 6
IE - Irlanda 6
LT - Lituania 6
CL - Cile 5
KE - Kenya 5
PY - Paraguay 5
UA - Ucraina 5
PK - Pakistan 4
TR - Turchia 4
AZ - Azerbaigian 3
EG - Egitto 3
JO - Giordania 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
SA - Arabia Saudita 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BO - Bolivia 2
CO - Colombia 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SN - Senegal 2
UZ - Uzbekistan 2
BB - Barbados 1
BE - Belgio 1
BF - Burkina Faso 1
BG - Bulgaria 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
HT - Haiti 1
HU - Ungheria 1
JM - Giamaica 1
LB - Libano 1
MK - Macedonia 1
MU - Mauritius 1
NP - Nepal 1
PA - Panama 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SV - El Salvador 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UG - Uganda 1
UY - Uruguay 1
YE - Yemen 1
YT - Mayotte 1
ZM - Zambia 1
Totale 4.607
Città #
Singapore 372
San Jose 276
Hefei 144
Moscow 138
Ashburn 128
Ho Chi Minh City 120
Hong Kong 118
Naples 99
Beijing 97
Hanoi 86
Chandler 67
Santa Clara 60
Munich 43
Amsterdam 35
New York 33
Lauterbourg 32
Seoul 29
Los Angeles 28
The Dalles 27
Tokyo 23
Frankfurt am Main 21
Redondo Beach 19
Boston 17
Council Bluffs 17
Haiphong 17
Buffalo 16
Orem 16
Dallas 15
Napoli 14
Nuremberg 14
Milan 13
São Paulo 13
Da Nang 12
Des Moines 10
Millbury 10
Afragola 9
Helsinki 9
Lappeenranta 9
Lawrence 9
Boardman 8
Dong Ket 8
Düsseldorf 8
Portsmouth 8
Rome 8
Toronto 8
Warsaw 8
Houston 7
Montreal 7
Poplar 7
Torre del Greco 7
Denver 6
London 6
Mexico City 6
San Francisco 6
Baghdad 5
Bexley 5
Biên Hòa 5
Brooklyn 5
Guayaquil 5
Las Vegas 5
Mumbai 5
Pune 5
Rio de Janeiro 5
Seattle 5
Stockholm 5
Turku 5
Wilmington 5
Woodbridge 5
Atlanta 4
Bari 4
Belo Horizonte 4
Borghetto Santo Spirito 4
Brasília 4
Can Tho 4
Cedar Knolls 4
Jakarta 4
Nanjing 4
Palermo 4
Paris 4
Phủ Lý 4
Quảng Ngãi 4
Santiago 4
Vĩnh Long 4
Điện Bàn 4
Amman 3
Bandung 3
Bengaluru 3
Campinas 3
Cape Town 3
Chicago 3
Dhaka 3
Madrid 3
Nairobi 3
Pattaya 3
Phoenix 3
Princeton 3
Quezon City 3
Ribeirão Preto 3
Roubaix 3
San Giuseppe Vesuviano 3
Totale 2.505
Nome #
Akap1 deficiency promotes mitochondrial aberrations and exacerbates cardiac injury following permanent coronary ligation via enhanced mitophagy and apoptosis 221
Correction: Akap1 deficiency promotes mitochondrial aberrations and exacerbates cardiac injury following permanent coronary ligation via enhanced mitophagy and apoptosis 177
Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trial 176
Different age-independent effects of nutraceutical combinations on endothelium-mediated coronary flow reserve 171
Acute Heart Failure and Non-Ischemic Cardiomyopathies: A Comprehensive Review and Critical Appraisal 156
Pharmacodynamic effects of cangrelor in elective complex PCI: insights from the POMPEII Registry 143
Extent of cardiac damage and mortality in patients undergoing transcatheter aortic valve implantation 141
Predictors of adherence to composite therapy after acute coronary syndromes 140
Prognostic Implications of Declining Hemoglobin Content in Patients Hospitalized With Acute Coronary Syndromes 138
Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention 137
Tako-tsubo syndrome and myocarditis: Two sides of the same coin or same side for two different coins? 135
Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale : The FABOLUS FASTER Trial 135
Changes and prognostic impact of noninvasive myocardial work indices in patients undergoing transcatheter aortic valve implantation 134
Echocardiographic Evaluation of Aortic Stenosis: A Comprehensive Review 134
Echocardiographic Evaluation after Transcatheter Aortic Valve Implantation: A Comprehensive Review 133
Incidence, predictors, and prognostic impact of temporary left bundle branch block after transcatheter aortic valve replacement 132
Hemodynamic Performance of Transcatheter Aortic Valves: A Comprehensive Review 131
Impact of COVID-19 pandemic on timing and early clinical outcomes of transcatheter aortic valve implantation 130
Is There Still a Role for Invasive Assessment of Aortic Gradient? 127
Effects of Guiding Catheter Disengagement on Resting Indexes for the Assessment of Coronary Artery Stenoses 125
Accuracy of global and regional longitudinal strain at peak of dobutamine stress echocardiography to detect significant coronary artery disease 124
Platelet Inhibition with Ticagrelor 60 mg Versus 90 mg Twice Daily in Elderly Patients with Acute Coronary Syndrome: Rationale and Design of the PLINY THE ELDER Trial 117
Evidence Supporting Criteria for Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Intervention 116
Correction to: Acute advanced aortic stenosis 115
Complete Revascularization in Acute and Chronic Coronary Syndrome 113
Myocardial Injury After Transcatheter Aortic Valve Replacement According to VARC-3 Criteria 109
Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions 109
Acute advanced aortic stenosis 107
Cangrelor, tirofiban, and chewed or standard prasugrel regimens in patients with st-segment-elevation myocardial infarction: Primary results of the FABOLUS-FASTER trial 104
Population Trends in Rates of Percutaneous Coronary Revascularization for Acute Coronary Syndromes Associated With the COVID-19 Outbreak 103
Venous Thromboembolism and Cancer: A Comprehensive Review from Pathophysiology to Novel Treatment 102
Pharmacodynamic effects of cangrelor in patients with acute or chronic coronary syndrome undergoing percutaneous coronary intervention: the POMPEII Registry 101
Impact of biomarker type on periprocedural myocardial infarction in patients undergoing elective PCI 99
Procedural and Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Narrative Review 99
Mortality after Bleeding versus Myocardial Infarction in Coronary Artery Disease: A Systematic Review and Meta-Analysis 98
Renin-angiotensin system inhibitors reduce cardiovascular mortality in hypertensive patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: insights from the EffecTAVI registry 96
Ultrathin Struts Drug-Eluting Stents: A State-of-the-Art Review 40
Invasive Diagnosis of HFpEF and ANOCA in a Patient With Effort Dyspnea and Angina 6
Totale 4.674
Categoria #
all - tutte 14.658
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.658


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202299 3 0 4 1 4 6 2 2 19 3 27 28
2022/2023169 12 13 9 12 16 20 0 12 33 29 13 0
2023/2024233 6 37 35 20 13 12 8 25 18 9 32 18
2024/20251.235 36 27 5 13 41 67 131 74 82 128 513 118
2025/20262.751 254 273 315 238 414 116 312 142 340 202 85 60
2026/202752 52 0 0 0 0 0 0 0 0 0 0 0
Totale 4.674